Global Western Blotting Market Analysis, Share, Trends and Forecast by 2025

The global western blotting market is anticipated to reach a value of USD 958.4 million by 2025, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of western blotting market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Browse the report: http://www.orbisresearch.com/reports/index/western-blotting-market-analysis-by-product-gel-electrophoresis-blotting-systems-imagers-consumables-by-application-biomedical-and-biochemical-research-disease-diagnostics-by-end-use-and-segment-forecasts-2014-2025

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Further key findings from the study suggest:
In 2016, consumables segment held the largest market share and is also expected to exhibit fastest growth over the forecast period owing to rising diagnostic and research-based activities requiring western blotting.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/267630

Amongst the application segment, biomedical & biochemical research contributed towards the largest revenue share in 2016 due to increasing government spending in proteomics research.

The disease diagnostics segment is anticipated to witness highest CAGR over the forecast period due to rising epidemiology of HIV, Lyme, and other related diseases.

Amongst the end-use segment, such as academic & research institutes dominated the market in 2016 owing to growing number of research activities conducted by educational institutions supported by government funding.

Buy the report@http://www.orbisresearch.com/contact/purchase/267630

The pharmaceutical and biotechnology companies are expected to grow at a significant CAGR over the forecast period due to increasing R&D spending by such companies.

Some of the key players are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, LI-COR Biosciences, Bio-Techne Corporation, PerkinElmer, Inc., and Merck KGaA.

Major Points From Table Of Contents:
Chapter One: Research Methodology
Chapter Two: Executive Summary
Chapter Three: Western Blotting Market Variables, Trends & Scope
Chapter Four: Western Blotting: Product Estimates & Trend Analysis
Chapter Five: Western Blotting: Application Estimates & Trend Analysis

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.